Hutrope 100 IU - Hubio Pharm

The development of HGH therapy transitioned dramatically in 1985, after the use of pituitary-derived hormone was banned due to contamination with Creutzfeldt-Jakob disease. That year, Genentech launched somatrem, the first recombinant HGH approved by the FDA. It served as a temporary solution until somatropin, an exact match to natural HGH, became available. With its 191-amino acid sequence, somatropin offered a safer and more consistent product, quickly replacing earlier methods and becoming the global standard in hormone therapy.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Hutrope 100 IU by Hubio Pharm, consult with your doctor or healthcare professional.